ADC Therapeutics SA
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -36.8% | +105.3% | -100.0% | – | +518.9% | -66.9% | +1.8% | +14.9% | |
| – | +38.1% | -8.9% | +31.9% | -99.0% | +137.0% | -23.4% | +135.2% | +29.0% | |
| – | – | – | -6,160.5% | – | +535.2% | -67.6% | -3.2% | +13.6% | |
| – | +38.3% | -9.1% | +32.1% | +11.2% | +18.0% | -31.8% | -13.8% | -5.1% | |
| – | +10.2% | +65.1% | +288.2% | +29.6% | +50.8% | -32.4% | -11.5% | -43.3% | |
| – | +36.0% | -4.2% | -36.4% | +279.9% | +12.1% | -29.4% | -16.1% | -6.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | +22.4% | -95.2% | +3,057.7% | +272.3% | +100.3% | +26.1% | +8.4% | +2.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +366.7% | +159.8% | -43.8% | -6,668.5% | – | +17,127.3% | -99.6% | -194.6% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.